Loading…
HTFL
Heartflow, Inc.
NASDAQ· Healthcare· Health Information Services· CUSIP 42238D107
$55.43-0.70%Price as of Oct 23, 00:53 UTC · updated once a day, after the close
At a glance
Heartflow, Inc. (HTFL) is listed on NASDAQ and classified in Health Information Services, part of the Healthcare sector. It is headquartered in San Francisco, United States and has 843 employees. The company is worth $4.82B. Revenue was $176.03M in fiscal 2025, up 39.9% from the year before. It reported a net loss of $116.79M. The share price is 3.2% below its 52-week high of $57.25. 6 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Steve Cohen (Point72 Asset Management), at $50.5M. In that quarter, 4 of them opened or added to the position and 1 reduced it. Over the last 30 days, company insiders sold $1.93M of its stock on the open market and bought none. All of those sales were scheduled in advance under 10b5-1 plans.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $4.82B
- P/E
- —
- Forward P/E
- —
- P/B
- 17.2x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$0.24
- ROE
- -154.23%
- Profit margin
- -55.82%
- Revenue growth
- +47.60%
- Beta
- —
- 52-week high
- $57.25
- 52-week low
- $20.13
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +53.3% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CRSPCRISPR Therapeutics AG | $49.99 | — | 2.8x | 0.00% | -26.09% | $4.83B |
| DFTXDefinium Therapeutics, Inc. | $36.00 | — | 5.3x | 0.00% | -64.09% | $4.84B |
| LFSTLifeStance Health Group, Inc. | $12.56 | 96.6x | 3.2x | 0.00% | 3.43% | $4.77B |
| RGCRegencell Bioscience Holdings Ltd |
About the company
- 843
- San Francisco, United States